Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

Pancreatic cancer will be positioned by the year 2030 as the second cause of oncological death after lung cancer. The pathophysiology of the most common variety, which involves the adenocarcinoma of the pancreas, represents one of the main challenges for current oncology to explain its tumorigenesis...

Full description

Bibliographic Details
Main Authors: Miguel A. Ortega, Leonel Pekarek, Oscar Fraile-Martinez, Cielo Garcia-Montero, Miguel A. Saez, Angel Asúnsolo, Miguel A. Alvarez-Mon, Jorge Monserrat, Lidia Ruiz-Llorente, Natalio García-Honduvilla, Agustin Albillos, Julia Buján, Melchor Alvarez-Mon, Luis G. Guijarro
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Current Oncology
Subjects:
pancreatic cancer
EGFR
Cyclin D1
CDK4
ErbB2
prognostic factors
Online Access:https://www.mdpi.com/1718-7729/29/4/198

Internet

https://www.mdpi.com/1718-7729/29/4/198

Similar Items